Recent Updates
Recently added Catalysts
RADX Positive Sentiment

Appendix 2A - Application for quotation of securities Announcement Summary Entity name RADIOPHARM THERANOSTICS LIMITED Announcement Type New announcement Date of this announcement Wednesday

Key Takeaway: RADIOPHARM THERANOSTICS LIMITED announced the application for the quotation of 30,969,360 ordinary fully paid securities on June 11, 2025. This move follows previously communicated transactions, as outlined in an Appendix 3B submission. The announcement is part of the company's strategy to enhance its market presence and issued capital structure. The firm continues to engage with the Australian Securities Exchange (ASX) in line with its regulatory obligations.
Price reaction · baseline $4.97 (2025-06-10 close) · hit after-hours · 3 other RADX headline(s) in the window, move may be shared
day 0 close
-5.8%
day 1
+7.2%
day 3
+3.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • RADIOPHARM THERANOSTICS has applied for quotation of a significant amount of new securities.
  • The application indicates ongoing financial transactions and engagement with the ASX.
  • The securities derive from prior announced transactions, signaling transparency.

Full Press Release Details

Announcement Summary
Entity name
RADIOPHARM THERANOSTICS LIMITED
Announcement Type
New announcement
Date of this announcement
Wednesday June 11, 2025
The +securities to be quoted are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B
Total number of +securities to be quoted
ASX +security code Security description Number of +securities to be quoted Issue date
RAD ORDINARY FULLY PAID 30,969,360 11/06/2025
Refer to next page for full details of the announcement
RADIOPHARM THERANOSTICS LIMITED
We (the entity named above) apply for +quotation of
the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.
1.2 Registered number type Registration number
ACN 647877889
1.3 ASX issuer code
RAD
+Securities issued as part of a transaction or transactions
previously announced to the market in an Appendix 3B
Previous Appendix 3B details:
Announcement Date and Time Announcement Title Selected Appendix 3B to submit quotation request
10-Jun-2025 17:35 New - Proposed issue of securities - RAD A placement or other type of issue
2.3a.2 Are there any further issues of +securities
yet to take place to complete the transaction(s) referred to in the Appendix 3B?
ASX +security code and description
RAD : ORDINARY FULLY PAID
Distribution Schedule
Provide a distribution schedule for the new +securities
according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities
held by the recipients in each category.
Number of +securities held Number of holders Total percentage of +securities held For example, to enter a value of 50% please input as 50.00
1 - 1,000 %
1,001 - 5,000 %
5,001 - 10,000 %
10,001 - 100,000 %
100,001 and over %
Number of +securities to be quoted
Are the +securities being issued for a cash consideration?
Please describe the consideration being provided for the +securities
Please provide an estimate (in AUD) of the value of
the consideration being provided per +security for the +securities to be quoted
Any other information the entity wishes to provide about the +securities to be quoted
Following the quotation of the +securities the
subject of this application, the issued capital of the entity will comprise:
The figures in parts 4.1 and 4.2 below are automatically
generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently
with ASX for processing.
ASX +security code and description Total number of +securities on issue
RADO : OPTION EXPIRING 30-NOV-2026 79,352,040
RAD : ORDINARY FULLY PAID 2,364,949,502
RADOA : OPTION EXPIRING 24-AUG-2026 818,890,534
ASX +security code and description Total number of +securities on issue
RADAK : OPTION EXPIRING 01-JUN-2027 EX $0.60 1,666,500
RADAE : OPTION EXPIRING 25-NOV-2025 RESTRICTED 5,700,006
RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 209,716,866
RADAJ : OPTION EXPIRING 01-JUL-2027 EX $0.17 13,137,976
RADAF : OPTION EXPIRING 25-NOV-2026 RESTRICTED 8,666,678
RADAG : OPTION EXPIRING 25-NOV-2026 EX $0.60 5,066,672
RADAH : OPTION EXPIRING 22-DEC-2025 EX $0.60 400,000
RADAI : OPTION EXPIRING 27-MAY-2027 EX $0.60 740,000
RADAP : OPTION EXPIRING 24-APR-2028 EX $0.09 8,955,224

Frequently Asked Questions

What securities are being quoted by Radiopharm Theranostics?

Radiopharm Theranostics is quoting 30,969,360 ordinary fully paid shares.

When was the announcement made for the security quotation?

The announcement for the security quotation was made on June 11, 2025.

How many fully paid ordinary shares are issued currently?

Currently, there are 2,364,949,502 fully paid ordinary shares issued.

What is the ASX issuer code for Radiopharm Theranostics?

The ASX issuer code for Radiopharm Theranostics is RAD.

What is the distribution schedule for the new securities?

The article does not specify the detailed distribution schedule for new securities.

Last updated: Jun 11, 2025